| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2023 | RESVITA BIO INC | 1261 64TH ST | EMERYVILLE | CA | 94608-1141 | ALAMEDA | USA | R43AI179327 | Skin probiotics to treat atopic dermatitis | 000 | 1 | NIH | 4/16/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,330,533 ) |
| | 2024 | 2024 | RESVITA BIO INC | 1261 64TH ST | EMERYVILLE | CA | 94608-1141 | ALAMEDA | USA | R44AR082240 | Skin probiotics to treat Netherton Syndrome | 000 | 2 | NIH | 9/20/2024 | $1,330,533 |
| | 2024 | 2022 | RESVITA BIO INC | 1261 64TH ST | EMERYVILLE | CA | 94608-1141 | ALAMEDA | USA | R43AR082240 | Skin probiotics to treat Netherton Syndrome | 000 | 1 | NIH | 4/23/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $249,935 ) |
| | 2023 | 2023 | RESVITA BIO INC | 1261 64TH ST | EMERYVILLE | CA | 94608-1141 | ALAMEDA | USA | R43AI179327 | Skin probiotics to treat atopic dermatitis | 000 | 1 | NIH | 7/1/2023 | $249,935 |
|
| Issue Date FY: 2022 ( Subtotal = $249,935 ) |
| | 2022 | 2022 | RESVITA BIO, INC. | 1261 64TH ST APT B | EMERYVILLE | CA | 94608-1141 | ALAMEDA | USA | R43AR082240 | Skin probiotics to treat Netherton Syndrome | 000 | 1 | NIH | 9/9/2022 | $249,935 |
|
|
